We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, ... Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer's disease; NMRA-266 for the treatment of schizophrenia and other neuropsychiatric disorders; NMRA-NMDA for the treatment of schizophrenia; NMRA-CK1d, a CK1d inhibitor program for the treatment of amyotrophic lateral sclerosis; NMRA-NLRP3 for the treatment of certain neurodegenerative conditions; and NMRA-GCase for the treatment of Parkinson's disease. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021. Show more
LINDON, Feb. 26, 2014 (GLOBE NEWSWIRE) -- MineralRite Corporation ("MineralRite") (OTCQB: RITE) and its wholly owned subsidiary, Goldfield International ("Goldfield") are pleased to announce the...
MineralRite and Goldfield Services Continue to Grow, Initial Order Expectation Beyond $200,000 LINDON, UT--(Marketwired - Feb 11, 2014) - MineralRite Corporation ("MineralRite") (OTCQB: RITE...
Lindon, Jan. 14, 2014 (GLOBE NEWSWIRE) -- MineralRite Corporation (OTCQB: RITE) is pleased to announce its Goldfield equipment fabrication facility which has a historic reputation for...
MineralRite Continues to Explore New Market Opportunities LINDON, UTAH--(Marketwired - Dec 30, 2013) - MineralRite Corporation (OTCQB: RITE) is pleased to announce that its Mineral Consultant...
MineralRite Gears Up for Active New Year LINDON, UTAH--(Marketwired - Dec 20, 2013) - MineralRite Corporation (OTCQB: RITE) is pleased to announce that its venture into Ghana, Africa has...
MineralRite Returns From Successful Trip to Africa LINDON, UT--(Marketwired - Nov 1, 2013) - MineralRite Corporation (OTCQB: RITE) a North American mineral processor focused on serving the...
MineralRite Capitalizes on Its Expertise for Innovation and Development for Its Clients LINDON, UT--(Marketwired - Oct 23, 2013) - MineralRite Corporation (OTCQB: RITE) is pleased to announce...
MineralRite Signs $600,000 Sales Agreement With Asian Corporation LINDON, UT--(Marketwired - Oct 9, 2013) - MineralRite Corporation (OTCQB: RITE) a North American mineral processor focused on...
We pay for 10 or more Pre-Promotion VIP early alert services so you don't have to. Ask any trader, what is the largest problem with trading micro-cap stocks? They will tell you that the...
MineralRite Copper Project Expected to Ship First 100 Ton in June PR Newswire LINDON, Utah, June 10, 2013 LINDON, Utah, June 10, 2013 /PRNewswire/ -- MineralRite Corporation (OTCQB: "RITE") is...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.61 | -4.85282418457 | 12.57 | 13.4105 | 11.5 | 862599 | 12.55305046 | CS |
| 4 | 1.61 | 15.5555555556 | 10.35 | 13.4105 | 10.01 | 726198 | 11.85449366 | CS |
| 12 | 2.94 | 32.5942350333 | 9.02 | 13.4105 | 8.33 | 853364 | 10.32025726 | CS |
| 26 | -3 | -20.0534759358 | 14.96 | 21 | 8.33 | 705560 | 11.69652529 | CS |
| 52 | -4.54 | -27.5151515152 | 16.5 | 21 | 8.33 | 539269 | 12.08304058 | CS |
| 156 | -4.54 | -27.5151515152 | 16.5 | 21 | 8.33 | 539269 | 12.08304058 | CS |
| 260 | -4.54 | -27.5151515152 | 16.5 | 21 | 8.33 | 539269 | 12.08304058 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
